In this episode of YBOS, Zarmeen speaks with PhD candidate Jason Day about his thesis work which looks to understand the phenomenology of the psychedelic experience. Jason theorizes a change in attention as a crucial aspect of the psychedelic experience. In this episode he explains his theory and also introduces a more controversial take on attention! Listen for more and be sure to check out the adjoining blog post. 

All content published by YBOS is solely the opinions of the authors and does not reflect the opinions of any parties affiliated with the authors or any additional third parties.

In this episode of YBOS, Alaina and Zarmeen talk about harm reduction! From the origins of these programs, to different forms of harm reduction across the board, to considerations for psychedelic assisted therapy… they’ve covered it all! Do you have any tips, tricks or favorite harm reduction groups? Let us know in the comments!

All content published by YBOS is solely the opinions of the authors and does not reflect the opinions of any parties affiliated with the authors or any additional third parties.

This week on YBOS, Alaina is joined by cannabis and psychedelic patent lawyer, Graham Pechenik. Here they'll discuss the big news in the world of psychedelics, clear up some misunderstood notions of patent law, and discuss how the psychedelic industry can potentially influence policy and what it all means moving forward to legalization (whatever that means) of psychedelics. 

The content of YBOS is the opinion of the authors and does not reflect the opinion of others or author affiliations.  

This week on Your Brain on Science, Alaina is joined by two fellow pharmacologist and activists, Lindsey Galbo-Thomma and Elijah Ullman. Join them as they talk about general concerns and ongoing discussions with the space of drug policy including decriminalization, harm reduction and more. 

The content of YBOS is the opinion of the authors and does not reflect the opinion of others or author affiliations.

Join Zarmeen and Alaina as they discuss the first paper for Journal Club 2023! This is one of the first 2023 clinical trial publications and focuses on a different kind of placebo, for the randomized placebo-controlled trial of psilocybin-assisted therapy for Major Depression Disorder. This study is super cool and has a lot of results that will (we think) propel the field forward. Check out our blog post with a link to the paper and let us know what you think! 

The content of YBOS is the opinion of the authors and does not reflect the opinion of others or author affiliations.

Welcome back to the official second season of Psychedelic Brain Science with Zarmeen and Alaina! This episode we're answering some listener questions and talking about some of the latest and greatest psychedelic news. We can't wait to bring you more content and get into some interesting topics this season! Stay tuned and reach out to us via email ([email protected]) or via our website psychedelicbrainscience.com.

All content published by YBOS is solely the opinions of the authors and does not reflect the opinions of any parties affiliated with the authors or any additional third parties.

Join Alaina and Zarmeen in the final episode of Season 1!! They are jumping right into all things microdosing. They'll get into methodology, clinical data, preclinical data and considerations for the field moving forward. Get ready for some strong opinions by self-identified "Microdosing Skeptic" Alaina. Catch the gals on the airwaves again in January for Season 2!

The content of YBOS is the opinion of the authors and does not reflect the opinion of others or author affiliations.

Alaina is joined this week by Dr. Lindsay Cameron, a PhD graduate from University San Diego and current post-doc at Stanford. This episode is all about that funny word, psychoplastogens, and how creating new compounds is kind of like taking a part a puzzle and using the pieces to make something new. Dr. Cameron talks about her work as a PhD student and the future directions of the field of psychedelics.

The content of YBOS is the opinion of the authors and does not reflect the opinion of others or author affiliations.

In this weeks episode Zarmeen kicks off the plasticity mini series with a dive into functional plasticity and current literature in the field. She talks about what exactly plasticity is (we know its been a psychedelic buzzword!) and how it intersects with psychiatric disorders. She also talks about different experimental measures of plasticity and of course, what we know of psychedelics and functional plasticity!

The content of YBOS is the opinion of the authors and does not reflect the opinion of others or author affiliations.

In this weeks episode Zarmeen talks to you about the Default Mode Network and its utility in theories of psychedelic action. This episode features special guest Haley Dourron a PhD student in psychology who talks about her Self Entropic Broadening theory which attempts to identify a mechanism for ego dissolution and separate the action of psychedelics from the historical belief that they are only useful as psychotomimetics. 

The content of YBOS is the opinion of the authors and does not reflect the opinion of others or author affiliations.